Eurofins Discovery USA
6 Research Park Drive
MO 63304
St. Charles
USA
Phone: +1 844 522 7787
US56_ProjectManagers@eurofinsus.com
www.eurofinsdiscovery.com
Get Directions
Eurofins Discovery provides a comprehensive portfolio of products and services to support your drug discovery and development needs from concept through to preclinical stages. Partnering with our clients, we provide both standard and specialized services to help you identify drug candidates with the desired properties to achieve clinical success. Eurofins acquired this entity in 2012, and has since added new Contract Research Organisations (CROS) and drug discovery companies to the network, including Cerep, Panlabs, DiscoverX®, Villapharma, Selcia/EID, and Beacon Discovery, expanding Eurofins Discovery capabilities and expertise.
Services include:
Target profiling
- IonChannelProfiler™ services
Discovery research products
- ChemiSCREEN™ and PrecisION® stable cell lines
- Ready-To-Assay™ frozen cells
- ChemiSCREEN™ membrane preps
Cellular phenotypic assays
- ImmunoSignal™ & cardiotoxicity
- OncoPanel™ Cell-based Profiling Services
- BioMAP® (Phenotypic)
ADME / Tox
- Solubility, permeability & metabolism
- Cardiotoxicity, hepatotoxicity & genotoxicity
Other areas of expertise include:
- First-to-market safety panel
- In vitro pharmacology
- Safety pharmacology
- Biologics characterisation
- Kinase products and services
- GPCR (G-Protein Coupled Receptors) products and services
- Kinase products
- Chemistry: synthetic, computational, and medicinal
- Integrated drug discovery (IDD)
- In vivo pharmacology
- High-throughput screening (HTS)
